About Lumicell Diagnostics
Lumicell Diagnostics is a company based in Wellesley (United States) founded in 2008 by Moungi Bawendi and W David Lee.. Lumicell Diagnostics has raised $360.8 million across 18 funding rounds from investors including HHS, LaunchCapital and BlueIO. The company has 23 employees as of December 31, 2023. Lumicell Diagnostics offers products and services including LumiSystem, LUMISIGHT, and Lumicell DVS. Lumicell Diagnostics operates in a competitive market with competitors including Averto Medical, On Target Laboratories, Huake Precision (Beijing) Medical Technology, C-RAD and US Medical Innovations, among others.
- Headquarter Wellesley, United States
- Employees 23 as on 31 Dec, 2023
- Founders Moungi Bawendi, W David Lee
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$360.8 M (USD)
in 18 rounds
-
Latest Funding Round
$198.13 M (USD), Series D
Apr 22, 2025
-
Investors
HHS
& 3 more
-
Employee Count
23
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lumicell Diagnostics
Lumicell Diagnostics offers a comprehensive portfolio of products and services, including LumiSystem, LUMISIGHT, and Lumicell DVS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Real-time system for detecting residual breast cancer during lumpectomy.
Agent that illuminates cancer for intraoperative visualization.
Technology for real-time cancer excision guidance in surgery.
Unlock access to complete
Funding Insights of Lumicell Diagnostics
Lumicell Diagnostics has successfully raised a total of $360.8M across 18 strategic funding rounds. The most recent funding activity was a Series D round of $198.13 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 18
- Last Round Series D — $198.1M
-
First Round
First Round
(02 Dec 2010)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series D - Lumicell Diagnostics | Valuation |
investors |
|
| Jul, 2024 | Amount | Series D - Lumicell Diagnostics | Valuation |
investors |
|
| Jul, 2024 | Amount | Debt – Conventional - Lumicell Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lumicell Diagnostics
Lumicell Diagnostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, LaunchCapital and BlueIO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in seed & early stage companies in the US
|
Founded Year | Domain | Location | |
|
Investments are made by BlueIO in early-stage technology companies.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lumicell Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lumicell Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lumicell Diagnostics Comparisons
Competitors of Lumicell Diagnostics
Lumicell Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Averto Medical, On Target Laboratories, Huake Precision (Beijing) Medical Technology, C-RAD and US Medical Innovations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for gastrointestinal disease patients are developed.
|
|
| domain | founded_year | HQ Location |
Molecular imaging agents for cancer surgery are developed.
|
|
| domain | founded_year | HQ Location |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| domain | founded_year | HQ Location |
Oncology treatments are delivered through standalone clinics.
|
|
| domain | founded_year | HQ Location |
Electrosurgery and plasma technology for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lumicell Diagnostics
Frequently Asked Questions about Lumicell Diagnostics
When was Lumicell Diagnostics founded?
Lumicell Diagnostics was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Where is Lumicell Diagnostics located?
Lumicell Diagnostics is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Who is the current CEO of Lumicell Diagnostics?
Howard Hechler is the current CEO of Lumicell Diagnostics.
Is Lumicell Diagnostics a funded company?
Lumicell Diagnostics is a funded company, having raised a total of $360.8M across 18 funding rounds to date. The company's 1st funding round was a Series D of $2.73M, raised on Dec 02, 2010.
How many employees does Lumicell Diagnostics have?
As of Dec 31, 2023, the latest employee count at Lumicell Diagnostics is 23.
What does Lumicell Diagnostics do?
Lumicell Diagnostics was established in 2008 in Wellesley, United States, within the medical imaging sector. Fluorescence-guided systems are created to support surgeons in visualizing residual cancer tissue in real time during operations. Single-cell detection capabilities are integrated, enabling evaluation of the tumor bed after initial resection. Operations focus on oncology applications, with potential to lower recurrence rates and limit needs for follow-up radiation or chemotherapy.
Who are the top competitors of Lumicell Diagnostics?
Lumicell Diagnostics's top competitors include Huake Precision (Beijing) Medical Technology, Averto Medical and On Target Laboratories.
What products or services does Lumicell Diagnostics offer?
Lumicell Diagnostics offers LumiSystem, LUMISIGHT, and Lumicell DVS.
Who are Lumicell Diagnostics's investors?
Lumicell Diagnostics has 4 investors. Key investors include HHS, LaunchCapital, BlueIO, and National Science Foundation.